G I-150 (Ibandronate sodium 150 mg (base))
Pill imprint G I-150 has been identified as Ibandronate sodium 150 mg (base).
Ibandronate is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for G I-150 (Ibandronate sodium 150 mg (base))
- 150 mg (base)
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
More about ibandronate
- Ibandronate oral/injection
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
- Other brands: Boniva
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...